CDMO
- Home
- CDMO
HAB Pharma offers integrated CDMO and manufacturing services, backed by over three decades of pharmaceutical manufacturing experience and an established production network in India. With three WHO-GMP-certified facilities and an annual production capacity of 4.4 billion+ units, we support pharmaceutical partners with consistent, large-scale manufacturing across a broad range of dosage forms.
Our approach brings together formulation expertise, established manufacturing processes and regulatory alignment to support products from development through commercialisation. Supported by integrated R&D capabilities and technology transfer expertise, we focus on developing formulations with the stability, scalability and process consistency required for commercial production.
Global Markets Served
WHO-GMP Certified Facilities
Years of Experience
From Development to Commercial Manufacturing
HAB Pharma operates as an integrated CDMO partner, connecting formulation development, analytical evaluation, technology transfer and commercial manufacturing within a coordinated development pathway. This integrated approach supports continuity from early-stage development to production at commercial scale.
Formulation Development and Technology Transfer
We support the development of stable, effective formulations and their transition to manufacturing. Technology transfer is structured to maintain process consistency while establishing the foundation for scalable production.
Analytical and Quality Systems
Validated analytical methods and structured quality systems support product integrity throughout development and manufacturing. These processes help establish consistency, evaluate product stability and maintain appropriate quality controls.
Manufacturing and Scale-Up
Our multi-facility manufacturing network supports the transition from pilot batches to commercial volumes. Established production processes and flexible capacity enable scale-up while maintaining process consistency.
Regulatory Support
Documentation, quality compliance and coordinated project execution form part of our approach to regulatory alignment. These systems support the development and manufacturing process across relevant stages of the product lifecycle.
Comprehensive Pharmaceutical Manufacturing Capabilities
HAB Pharma’s manufacturing infrastructure spans key pharmaceutical dosage forms, supported by formulation development capabilities for specialised product requirements. Our R&D capabilities extend to complex formulations, including modified-release systems, enteric coatings and specialised drug-delivery platforms, supporting the development of differentiated products.
Tablets and Capsules
Oral solid dosage forms supported by established manufacturing capabilities across our production network.
Injectable Formulations
Dedicated sterile manufacturing capabilities for injectable products.
Oral Liquids and Drops
Manufacturing capabilities for liquid formulations and drop-based dosage forms.
Ointments and Topical Preparations
Production capabilities spanning topical formulations and external preparations.
Aerosols and Oral Jelly Formats
Specialised dosage-form capabilities encompassing aerosols and oral jelly products.
Multi-Facility Manufacturing Capabilities
HAB Pharma’s manufacturing network comprises three facilities across Vasai, Mumbai, and Selaqui, Dehradun, operating across six production blocks and supported by a workforce of 600+ professionals.
This integrated network provides operational flexibility, enables efficient allocation of production loads and supports consistent manufacturing output across markets. The combined capabilities of our facilities include:
- Oral solid manufacturing across all units
- Dedicated sterile manufacturing for injectables
- Liquid, topical, and aerosol production capabilities
- Flexible packaging lines including blister, tube, and pouch formats
Quality Systems and Regulatory Readiness
Quality is integral to HAB Pharma’s approach to pharmaceutical development and manufacturing. Our facilities are WHO-GMP-certified, and our quality systems are aligned with ISO 9001:2015 requirements.
Guided by Quality by Design principles, our approach emphasises the importance of consistency, stability and product performance from the formulation stage onwards. Structured quality assurance frameworks, documented processes and established controls support process oversight from R&D through commercial production.
By integrating quality considerations throughout the development and manufacturing pathway, we work to support reproducibility, regulatory readiness and consistent manufacturing outcomes.
From Formulation to Commercial Manufacturing
HAB Pharma follows a structured development pathway to support the transition from an initial formulation concept to commercial production. Each stage contributes to establishing product characteristics, evaluating stability and preparing the formulation for manufacturing.
- Pre-formulation and compatibility studies
- Formulation development and optimization
- Analytical validation and stability studies
- Technology transfer to manufacturing
- Commercial-scale production
Global Supply Capabilities
HAB Pharma supplies products to international markets across multiple regions. Our export reach includes:
- South Asia
- Southeast Asia
- Middle East
- Africa
- Latin America
Why Partner With HAB Pharma?
Together, these capabilities position HAB Pharma to support pharmaceutical partners
seeking an experienced manufacturing collaborator across development, technology
transfer and commercial production.
An Integrated Development-to-Manufacturing Model
Our CDMO capabilities connect formulation development, technology transfer and commercial production within a coordinated framework, supporting continuity throughout the product lifecycle.
Formulation R&D (Vasai)
Pre-formulation chemistry, API compatibility screenings, reverse engineering, and lab-scale trial batches.
Tech Transfer Protocol
Standardized BMR/BPR translation, process validation matrices, and analytical parameter qualification.
Commercial Manufacturing (Dehradun)
High-throughput automated compression, encapsulation, aseptic filling, and multi-market commercial packaging.
Established Manufacturing Scale
Three WHO-GMP-certified facilities, six production blocks and an annual production capacity of 4.4 billion+ units provide a manufacturing platform designed to support diverse production requirements.
Broad Dosage-Form Capabilities
From tablets and capsules to injectables, liquids, topical preparations and specialised formats, our manufacturing network accommodates a wide range of pharmaceutical dosage forms. R&D capabilities also extend to complex formulations, including modified-release systems and enteric coatings.
Tablets (uncoated, film, bilayer), Capsules & Multi-particulate Pellets
Ampoules, Vials, and Lyophilised preparations in isolator units
Ointments, Creams, Gels and topical emulsions
Syrups, pediatric drops, and homogeneous liquid suspensions
Modified-release (SR/ER), Enteric-coated & Taste-masked microgranules
Quality and Regulatory Alignment
Quality systems, structured documentation and established process controls underpin our approach to development and manufacturing, supporting consistency and regulatory readiness.
21 CFR Part 11 electronic batch audit trails and automated instrument logs.
Full readiness for Modules 2 & 3 (Quality Overall Summary & Body of Data).
WHO-GMP, NAFDAC, Iraq MoH, Uganda NDA & Libya FDA verified compliance.
International Market Experience
With products supplied across South Asia, Southeast Asia, the Middle East, Africa and Latin America, HAB Pharma brings experience in serving pharmaceutical markets across multiple regions.
Validated climate-controlled shipping logistics with calibrated real-time data loggers ensuring ICH stability conditions from facility gates to discharge port.
Start Your Manufacturing Partnership
Partner with HAB Pharma for contract development and manufacturing services built around established expertise, scalable production capabilities and a quality-driven approach.
- A-301, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel (West), Mumbai – 400013.
- info@habpharma.in
- 022-66261400